HemeTalks: Conversations in Hematology Education

HemeTalks: Conversations in Hematology Education

American Society of Hematology
Country USA
Language EN
Episodes 37
Latest 19.11.2026

HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.

Episodes

  • The Predicament of Patients in Prison: A Hematology Perspective
    The Predicament of Patients in Prison: A Hematology Perspective 19.11.2026 30m
    Dr. Michael DeBaun, Professor of Pediatrics and Medicine at Vanderbilt University Medical Center, joins HemeTalks hosts Drs. Ronak Mistry and Vivek Patel to discuss a population often left out of conversations about equitable hematologic care: patients who are incarcerated or moving through the criminal legal system. Nearly 80 million Americans carry a criminal record, and incarceration is associated with higher rates of chronic disease, morbidity, and mortality. The conversation examines what quality hematologic care looks like inside correctional facilities, what happens at the moment of rel...
  • Beyond Vaso-Occlusion: The Hidden Pathways Driving Sickle Cell Disease
    Beyond Vaso-Occlusion: The Hidden Pathways Driving Sickle Cell Disease 05.11.2026 26m
    In this episode of HemeTalks: Conversations in Hematology, hosts Dr. Ronak Mistry and Dr. Vivek Patel are joined by Dr. Enrico Novelli, Professor of Medicine at the University of Maryland and leader of its sickle cell disease program, for a deep dive into the biology and management of sickle cell disease. Dr. Novelli unpacks molecular pathways beyond vaso-occlusion, including hyper-adhesion, oxidative stress, and hemolysis, that drive disease complications and are opening the door to new therapeutic targets. The conversation covers why hydroxyurea remains the treatment backbone despite being u...
  • Immune Thrombocytopenic Purpura: The Patient Perspective
    Immune Thrombocytopenic Purpura: The Patient Perspective 15.10.2026 25m
    In this patient advocate episode, Ms. Barbara Pruitt shares what it's like to live with immune thrombocytopenia (ITP), a condition she has had since age four. Barbara takes us through more than six decades of treatments, from childhood steroids and a splenectomy to today's newer therapies. She describes growing up without meeting anyone else with ITP and the moment a patient organization changed that. She also talks about the everyday adjustments that let her keep traveling, dancing, and enjoying life, and how a hematologist's words can either wound or empower. Hosts Drs. Ronak Mistry and Vive...
  • From Aplastic Anemia to PNH: The Patient Perspective
    From Aplastic Anemia to PNH: The Patient Perspective 01.10.2026 28m
    In this episode of HemeTalks, we are joined by Ms. Elise Burton, who shares her experience living with paroxysmal nocturnal hemoglobinuria (PNH). Elise describes how her journey began several years earlier with a diagnosis of aplastic anemia, before her condition was later recognized as PNH after she developed evidence of unexplained hemolysis. She walks through her treatment journey, including eculizumab, ravulizumab, and enrollment in a danicopan clinical trial, as well as the side effects she experienced, the financial navigation required to stay on therapy, and the routine health maintenan...
  • Caring for Young Adults with Sickle Cell Disease
    Caring for Young Adults with Sickle Cell Disease 17.09.2026 29m
    Dr. Cece Calhoun (Yale School of Medicine) joins Heme Talks to discuss one of the most vulnerable moments in sickle cell care: the transition from pediatric to adult management. Using a real case of a 24-year-old with hemoglobin SC disease re-establishing care after a lapse, Dr. Calhoun walks through how to build trust with adolescent and young adult patients, why sickle cell disease is a systemic vascular and inflammatory condition rather than "just pain," and how to explain complex pathophysiology in patient-friendly language. The conversation covers essential screening guidelines for new ad...
  • From Steroids to Cure: A Modern Approach to Immune Thrombocytopenic Purpura (ITP)
    From Steroids to Cure: A Modern Approach to Immune Thrombocytopenic Purpura (ITP) 03.09.2026 29m
    Immune thrombocytopenic purpura (ITP) is a diagnosis of exclusion but treating it is anything but straightforward. In this episode, Dr. Adam Cuker (University of Pennsylvania) joins us to break down how the management of ITP is evolving in real time, from diagnostic pitfalls to a preview of the newly released ASH ITP guidelines. We cover first-line corticosteroid strategies, when to add IVIG, how to choose between the many other available options in the second line and later settings. A world-expert in ITP management, Dr. Cuker shares many important clinical pearls and management strategies to...
  • Blasting Through B-ALL: Modern Management from Induction to CAR T
    Blasting Through B-ALL: Modern Management from Induction to CAR T 20.08.2026 30m
    In this episode of HemeTalks, we dive into the evolving landscape of B-cell acute lymphoblastic leukemia (B-ALL) management with Dr. Adam DuVall. We begin with newly diagnosed disease, discussing which patients qualify for asparaginase containing pediatric inspired induction regimens. We then shift to the relapsed/refractory setting, exploring the roles of blinatumomab and inotuzumab ozogamicin as off-the-shelf therapies. Finally, we take a deep dive into CAR T cell therapy — comparing the three approved products, their costimulatory domains, toxicity profiles, and the growing evidence support...
  • Peripheral T-Cell Lymphoma: Navigating Diagnosis, Relapse, and Emerging Treatment Strategies
    Peripheral T-Cell Lymphoma: Navigating Diagnosis, Relapse, and Emerging Treatment Strategies 06.08.2026 31m
    Episode Description:In this episode of HemeTalks, we are joined by Neha Mehta-Shah, MD, MSCI, Associate Professor of Medicine at Washington University in St. Louis, to discuss the evolving management of peripheral T-cell lymphomas (PTCL), with a focus on differences by histologic subtype. Through a case-based discussion, Dr. Mehta-Shah explores the diagnostic challenges of PTCL, including the role of repeat biopsies, expert pathology review, and molecular testing. She reviews frontline treatment approaches, including CHOP-, CHOEP-, and brentuximab vedotin-based regimens, and discusses the role...
  • Warm Autoimmune Hemolytic Anemia: The Patient Perspective
    Warm Autoimmune Hemolytic Anemia: The Patient Perspective 16.07.2026 30m
    In this episode of HemeTalks, we are joined by Mr. Sean Powell as he shares his experiences as a former patient and now patient advocate for a rare blood disorder known as warm autoimmune hemolytic anemia (wAIHA). Sean shares his story of how he was diagnosed, the initial management, drug toxicities, and subsequent investigations that he underwent. Our patient advocate episodes highlight the importance of advocacy, community, and shared understanding between patients and their healthcare providers. Key Takeaways1. wAIHA can sometimes be associated with an underlying condition. Mr. Powell’s jou...
  • Warm Autoimmune Hemolytic Anemia: Challenges, Choices, and New Therapies
    Warm Autoimmune Hemolytic Anemia: Challenges, Choices, and New Therapies 02.07.2026 28m
    In this episode of Heme Talks, we are joined by Allyson Pishko, MD, MSCE, Classical Hematologist and Assistant Professor of Medicine at the University of Pennsylvania, to discuss a rare blood disorder known as warm autoimmune hemolytic anemia (wAIHA). In this episode, Dr. Pishko shares her approach to diagnosis and management of this disorder, and how she approaches discussions about this diagnosis with her patients. Dr. Pishko also discusses promising future options for patients with wAIHA. Clinical Perls:Warm autoimmune hemolytic anemia is a complex diagnosis. In addition to a careful histor...
  • Unfolding Amyloid: A Patient Perspective
    Unfolding Amyloid: A Patient Perspective 18.06.2026 30m
    In this episode of Heme Talks, we are joined by Dr. Sai Jambunathan as she shares her experiences with the diagnosis and management of a rare blood disorder known as AL amyloidosis. As a patient herself, listeners will gain insights into the complex initial workup and what the treatment journey is like for patients with this condition. Our patient advocate episodes highlight the importance of advocacy, community, and shared understanding between patients and their healthcare providers. Key Takeaways:AL amyloidosis can present without classic symptoms, making early recognition challenging. Dr....
  • Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status
    Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status 04.06.2026 20m
    Join Dr. Maureen Achebe and Dr. Lauren Merz for an in‑depth exploration of the Absolute Neutrophil Counts (ANC) by Duffy Status project, a multicenter effort to define what “normal” ANC and white blood cell counts (WBC) look like in people with the erythrocyte Duffy null variant. Using data from 23 sites across the United States, the project established Duffy null-specific ANC and WBC reference intervals for both adults and children as well as highlighted how often healthy Duffy null individuals have ANC and WBC that fall below conventional laboratory cutoffs. The episode unpacks the key findi...
  • Multiple Myeloma Care: Timing, Teamwork, Treatment
    Multiple Myeloma Care: Timing, Teamwork, Treatment 21.05.2026 23m
    Multiple myeloma care is evolving faster than ever, with new therapies, treatment strategies, and possibilities emerging at an unprecedented pace. In this episode, hematologist Dr. Devarakonda and Kathy Giusti, founder of the Multiple Myeloma Research Foundation, come together for a candid, practical conversation about what this rapid progress means for patients, caregivers, and providers.They explore why where you’re treated matters, how timing, sequencing, and dosing decisions shape outcomes, and what it takes to be an informed patient in today’s complex care environment. Through real-world...
  • Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento
    Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento 21.05.2026 22m
    La atención del mieloma múltiple está evolucionando más rápido que nunca, con la aparición de nuevas terapias, estrategias de tratamiento y posibilidades a un ritmo sin precedentes. En este episodio, el hematólogo Dr. Devarakonda y Kathy Giusti, fundadora de la Multiple Myeloma Research Foundation (Fundación para la Investigación del Mieloma Múltiple), se reúnen en una conversación sincera y práctica sobre lo que este rápido avance significa para los pacientes, sus cuidadores y el personal de salud.Ambos analizan por qué el lugar donde recibes el tratamiento es crucial, cómo las decisiones sob...
  • TTP Today: Diagnosis, Management & Evolving Therapies
    TTP Today: Diagnosis, Management & Evolving Therapies 07.05.2026 19m
    TTP is a hematologic emergency that demands immediate recognition and treatment to prevent fatal outcomes. In this HemeTalks episode, Dr. Yazan Abou-Ismail and Dr. Kolton Smith discuss the diagnostic hallmarks, therapeutic advances, and follow-up strategies for patients with TTP.Through the lens of a clinical case, they explore the impact of caplacizumab, the importance of ADAMTS13 testing, and how to differentiate TTP from other TMAs. Tune in for practical insights that every hematologist and frontline provider should know.Learning Objectives:Recognize clinical and laboratory features indicat...
  • Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring
    Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring 16.04.2026 25m
    Join us for an insightful discussion on myelodysplastic neoplasms (or MDS) with Drs. DeZern and Mack as we review the current standards in diagnosis of MDS using cutting edge molecular techniques. This marrow failure syndrome requires thoughtful and accurate diagnosis to ensure appropriate risk assessment for clinical decision making. We will then review relevant therapeutic choices and how to monitor on and off therapy through the case of a 68 yo male with a 6-year history of disease. We will explore key diagnostic considerations, the distinct testing required for prognostication and the ther...
  • New Horizons in Smoldering Multiple Myeloma
    New Horizons in Smoldering Multiple Myeloma 19.03.2026 26m
    Join Professor Brea Lipe and Professor Sagar Lonial as they discuss the changing treatment landscape of smoldering multiple myeloma (SMM). With a recently approved treatment for high-risk SMM, knowing how to differentiate and manage SMM compared with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) has never been more crucial. Professors Lipe and Lonial review the case of a 58-year-old man in good health with no anemia or other health concerns, whose annual checkup reveals an isolated finding of elevated total protein. As they follow this patient’s journey, t...
  • Interpreting Abnormal SPEP – Is It Just MGUS?
    Interpreting Abnormal SPEP – Is It Just MGUS? 19.02.2026 27m
    Monoclonal gammopathy of undetermined significance (MGUS) is a common but often confusing finding on serum protein electrophoresis (SPEP) reports. In this HemeTalks episode, Drs. Rahma Warsame and Jason Chen discuss how to interpret abnormal SPEP results, evaluate patients with suspected MGUS, and differentiate between benign and concerning findings. Using real-world cases, they highlight key clinical decision points, follow-up strategies, and how to communicate results with patients effectively. Tune in for expert guidance on navigating this diagnostic gray zone in hematology.Learning Objecti...
  • Sticky Situations: The Role of Thrombophilia Testing in VTE Management
    Sticky Situations: The Role of Thrombophilia Testing in VTE Management 15.01.2026 28m
    In this episode, Drs. Ronak Mistry and Jori May discuss the challenging decision of when to test for inherited thrombophilias and how results inform anticoagulation management. The use of thrombophilia testing has long been debated in the hematology community, due in large part to limited data and the complexity of estimating recurrent thrombotic risk. Through the case of a 36-year-old woman with a proximal deep vein thrombosis 4 weeks after an uncomplicated vaginal delivery, we explore the importance of defining provoking factors, evaluating bleeding risk, exploring previous thrombotic challe...
  • Lost in Translation: The aHUS Experience
    Lost in Translation: The aHUS Experience 18.12.2025 20m
    In this episode of HemeTalks, Alyssa Deffenbaugh and Dr. Toyosi Onwuemene explore the challenges of diagnosing, managing, and living with atypical hemolytic uremic syndrome (aHUS). Listeners will gain insight from a patient advocate and individual living with aHUS, as well as a physician who supports patients through diagnosis and ongoing management. Together, they highlight the importance of advocacy, community, and building a shared understanding between patients and providers. Learning Objectives: By the end of this episode, listeners will be able to: Describe at least two challenges indivi...

Popular in

The podcast also appears in the podcast charts of these countries.